Program Description:

This is part II of a three-part series of case-based articles on optimal, evidence-based approaches to the management of gout, an inflammatory arthritis that over the past two decades has doubled in prevalence in the United States. Here, management approaches are outlined for a patient with stage 3 chronic kidney disease and hypertension. He presents with an acute gout flare—an occurrence that is becoming more frequent.

INTENDED AUDIENCE:

This activity has been designed to meet the educational needs of nephrologists and other clinicians involved in the treatment of patients with gout.

Activity Objectives:

After completing the activity, the participant should be better able to:

— Describe how renal function affects the management of gout.
— Evaluate current and emerging options for urate-lowering therapy with regard to their benefits and limitations in patients with varying degrees of renal impairment.
— Discuss ways to motivate patient adherence to a long-term treatment plan that incorporates lifestyle considerations and pharmacotherapy.

    STATEMENT OF NEED

    Clinicians today face an increasing number of patients with gout. Nephrologists in particular must contend with complex cases in patients with varying degrees and stages of renal dysfunction in addition to other comorbidities and individual characteristics that affect treatment decisions and, ultimately, treatment success. As gout occurs in tandem with renal disorders, nephrologists must be able to appropriately identify and treat these patients.

    To take this course, go to mycme.com. The log-in information for myCME is the same as McKnight’s. Please note that you will need to complete additional registration information.